Besivance Side Effects

Generic name: besifloxacin ophthalmic

Medically reviewed by Drugs.com. Last updated on Nov 1, 2024.

Note: This document provides detailed information about Besivance.

Applies to besifloxacin ophthalmic: ophthalmic suspension Side Effects associated with besifloxacin ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Besivance.

Applies to besifloxacin ophthalmic: ophthalmic suspension.

Precautions

If your eye infection does not improve, or if it becomes worse, check with your doctor.

Stop using this medicine and check with your doctor right away if you have a rash, itching, or red or swollen skin around the eye or eyelid. These may be symptoms of an allergic reaction.

Do not wear contact lenses while you are using this medicine to avoid further eye irritation.

Serious side effects of Besivance

Along with its needed effects, besifloxacin ophthalmic (the active ingredient contained in Besivance) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking besifloxacin ophthalmic:

Other side effects of Besivance

Some side effects of besifloxacin ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For healthcare professionals

Applies to besifloxacin ophthalmic: ophthalmic suspension.

Ocular adverse events

• Common (1% to 10%): Conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, conjunctivitis, bacterial conjunctivitis
• Uncommon (0.1% to 1%): Eyelid edema, conjunctival edema, corneal infiltrates, punctate keratitis, eye discharge, conjunctival hemorrhage, conjunctival disorder, dry eye, limbal hyperemia, conjunctival hyperemia, viral conjunctivitis, ocular hyperemia, reduced visual acuity, eyelid erythema, keratoconjunctivitis sicca, corneal staining, eyelid margin crusting
• Postmarketing reports: Corneal deposits, corneal disorders, corneal edema, corneal opacity, corneal striae, eye edema, foreign-body sensation in eyes, increased lacrimation, ocular discomfort, photophobia, corneal dystrophy, anterior chamber disorder, blepharitis, corneal pigmentation, corneal scar, corneal thickening, eye inflammation, eye swelling, glare, halo vision, meibomian gland dysfunction, strabismus, ulcerative keratitis, visual impairment, endophthalmitis, hypopyon, corneal flap complication, diffuse lamellar keratitis, eye burn, eye injury, foreign body in eye, increased intraocular pressure, abnormal visual acuity test^[Ref]

Nervous system

• Common (1% to 10%): Headache
• Postmarketing reports: Dizziness, dysgeusia, presyncope^[Ref]

Other

• Uncommon (0.1% to 1%): Otitis media, ear infection
• Postmarketing reports: Off-label use, impaired healing, medication residue, edema, drug ineffective (including for unapproved indication), gait disturbance, malaise, peripheral edema, pyrexia, candidiasis, staphylococcal infection, inappropriate schedule of drug administration, incorrect dose administered, incorrect drug dose form administered^[Ref]

Respiratory

• Uncommon (0.1% to 1%): Sinusitis, nasopharyngitis, upper respiratory tract infection, pharyngolaryngeal pain, nasal congestion, respiratory tract congestion, asthma, cough
• Postmarketing reports: Dry throat, dyspnea, throat tightness^[Ref]

Psychiatric

• Uncommon (0.1% to 1%): Depression
• Postmarketing reports: Disorientation, insomnia^[Ref]

Cardiovascular

• Postmarketing reports: Increased blood pressure, endothelial dysfunction^[Ref]

Dermatologic

• Postmarketing reports: Cold sweat, madarosis, photosensitivity reaction^[Ref]

Gastrointestinal

• Postmarketing reports: Diarrhea, dysphagia, frequent bowel movements, gingival pain, glossodynia, mucous stools, nausea, sensitivity of teeth^[Ref]

Local

• Postmarketing reports: Instillation site pain^[Ref]

Metabolic

• Postmarketing reports: Increased blood glucose, hypokalemia^[Ref]

Musculoskeletal

• Postmarketing reports: Muscle spasm^[Ref]

See also:

Further information

Besivance side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer